Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression

Area of Science:

• Vascular Biology
• Biochemistry
• Molecular Biology

Background:

• Nitric oxide (NO) plays a role in regulating vessel wall remodeling.
• NO may influence matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) expression.
• Understanding the interaction between NO and MMPs/TIMPs is crucial for vascular health.

Purpose of the Study:

• To investigate the effect of nitric oxide synthase (NOS) inhibition on cytokine-stimulated MMP and TIMP expression in aortic tissue.
• To test the hypothesis that NOS inhibition leads to increased MMP and TIMP expression.
• To elucidate the role of NO in regulating matrix remodeling processes.

Main Methods:

• Cultured rat aortic segments were treated with varying concentrations of N(G)-monomethyl-l-arginine (L-NMMA), a NOS inhibitor.
• Interleukin-1beta was used to stimulate NOS, MMP, and TIMP expression.
• Nitrate/nitrite (NOx) levels, MMP activity (zymography), MMP/TIMP protein and mRNA levels (Western blot, RT-PCR) were measured.

Main Results:

• L-NMMA treatment caused a dose-dependent decrease in NO(x) levels.
• A dose-dependent increase in MMP-9 activity, protein, and mRNA was observed.
• MMP-2 activity increased, but its protein and mRNA levels remained unchanged.
• TIMP-1 activity increased, while its mRNA levels did not change.

Conclusions:

• NOS inhibition in ex vivo aortic tissue results in a dose-dependent increase in MMP-9 expression and activity.
• These findings suggest that NO deficiency in vivo could disrupt MMP and TIMP homeostasis, potentially leading to matrix degradation.
• The study highlights the critical role of NO in maintaining vascular matrix integrity.